20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T34532 | Sari 59-801 | Sari-59-801 | Others |
Sari 59-801 is a novel, orally effective hypoglycemic compound. | |||
T10353 | APX-115 free base | Ewha-18278 free base | NADPH-oxidase , NADPH |
APX-115 free base (Ewha-18278 free base) (Ewha-18278 free base) is a potent, orally active pan NADPH oxidase (Nox) inhibitor (Kis: 1.08 μM, 0.57 μM, and 0.63 μM for Nox1, Nox2, and Nox4). APX-115 effectively prevents kid... | |||
T2P2919 | (2S,3R,4S)-4-Hydroxyisoleucine | (4S)-4-Hydroxy-L-isoleucine,Hydroxyisoleucine | PI3K |
(2S,3R,4S)-4-Hydroxyisoleucine (Hydroxyisoleucine) from fenugreek (Trigonella foenum-graecum) seeds is a potential insulinotropic (anti-diabetic) and anti-obesity amino acid. HIL stimulates glucose-dependent insulin secr... | |||
TCS1772 | Dehydroabietic acid | Dehydroabietate | Antifection |
1. Dehydroabietic acid (Dehydroabietate) (DAA) is an EBV-EA activation inhibitor. 2. DAA is a useful food-derived compound for treating obesity-related diseases, by decreasing plasma glucose, insulin levels, plasma trigl... | |||
T33412 | MitoPQ | MitoParaquat | Glucokinase , transporter |
MitoPQ (MitoParaquat) is a mitochondria-targeted small molecule compound that selectively enhances mitochondrial superoxide and hydrogen peroxide levels and inhibits insulin-stimulated glucose uptake and translocation of... | |||
TWO2727 | Propane-1,2,3-triyl tripalmitate | Palmitic Triglyceride,Tripalmitin,Tripalmitoylglycerol,Glycerol Tripalmitate | Others , Endogenous Metabolite |
Propane-1,2,3-triyl tripalmitate (Glycerol Tripalmitate) is a triacylglycerol found in dietary fats. Tripalmitin increases body weight and plasma LDL levels and reduces hepatic LDL receptor mRNA levels in hamsters fed a ... | |||
T80149 | GRPP (human) | ||
GRPP (human), a 30-amino-acid peptide derived from Gcg, modestly elevates plasma insulin levels while reducing plasma glucagon concentrations. However, GRPP (human) has no impact on insulin secretion within rat islets [1... | |||
T64553 | GLP-1(7-37) TFA salt | ||
The truncated glucagon-like peptides GLP-1(7-37) is naturally occurring peptide product of the preproglucagon gene that are synthesized primarily in the intestine and acts as incretin that are released from the intestine... | |||
TP2020 | [Pro3]-GIP (Mouse) | ||
GIP receptor antagonist (IC50 = 2.6μM). Inhibits GIP-stimulated insulin release from pancreatic β cells in vitro. In ob/ob mice, blocks the effects of GIP on insulin release and plasma glucose levels. Also improves intra... | |||
TMA0127 | Ficusin A | transporter , PPAR | |
Ficusin has antioxidant, antilipidemic and antidiabetic effects, it can lower the levels of fasting blood glucose, plasma insulin, body weight gain in HFD-STZ induced diabetic rats, and can significantly enhance the PPAR... | |||
T35808 | C18:1 Ceramide (d18:1/18:1(9Z)) | Cer(d18:1/18:1(9Z)) | |
C18:1 Ceramide is a naturally occurring ceramide.[1][2][3] Levels of C18:1 ceramide are elevated in overweight and insulin-resistant mice and cattle.[1][2] C18:1 Ceramide is also increased in the plasma and ovarian tissu... | |||
T37120 | 1,2,3-Triundecanoyl Glycerol | ||
1,2,3-Triundecanoyl glycerol is a triacylglycerol that contains undecanoic acid at thesn-1,sn-2, andsn-3 positions. Dietary administration of a 7:3 (w/w) mixture of 1,2,3-triundecanoyl glycerol and corn oil prevents fast... | |||
T82143 | Hylambatin | ||
Hylambatin, a tachykinin, elevates plasma glucose and insulin levels without altering glucagon secretion, and is utilized in diabetes research [1]. | |||
T30538 | BMS-695735 | CHEMBL459729,DNC008930,BMS 695735,BMS695735,BDBM27888 | |
BMS-695735, a benzimidazole inhibitor of insulin-like growth factor-1 receptor, has broad-spectrum antitumor activity in vivo. It was found that BMS-695735 had strong inhibition of CYP3A4, induction of CYP3A4 mediated by... | |||
T36791 | Lysophosphatidylcholine 18:2 | ||
1-Linoleoyl-2-hydroxy-sn-glycero-3-PC (LGPC) is a lysophospholipid containing linoleic acid at thesn-1 position that has been found in mouse heart, lung, liver, spleen, kidney, plasma, and serum.1Serum levels of LGPC dec... | |||
T35809 | C20 Sphingomyelin (d18:1/20:0) | ||
C20 Sphingomyelin is a naturally occurring sphingolipid. Levels of C20 sphingomyelin are upregulated in the hippocampus of rats with diabetes induced by streptozotocin and in human plasma where it is positively correlate... | |||
T35804 | C16 Lactosylceramide (d18:1/16:0) | ||
C16 Lactosylceramide is an endogenous bioactive sphingolipid. It forms membrane microdomains with Lyn kinase and the αi subunits of inhibitory G protein-coupled receptors (GPCRs), suggesting a role in cell signaling. Pla... | |||
T83696 | Gastric Inhibitory Peptide 1 (3-42) (human) TFA | Glucose-dependent Insulinotropic Polypeptide 3-42,GIP-1 (3-42) | |
Gastric inhibitory peptide 1 (GIP-1) (3-42), a fragment of the incretin hormone GIP and antagonist to the GIP receptor, is generated through the action of serum dipeptidyl peptidase 4 (DDP-4). When administered at 25 nmo... | |||
T73434 | BI-2081 | ||
BI-2081, a GPR40 (FFAR1) partial agonist with an EC50 of 4 nM, promotes glucose-dependent insulin secretion and lowers plasma glucose levels. This compound is utilized in metabolic disease research, specifically targetin... | |||
T68976 | Piragliatin | ||
Piragliatin, also known as RO4389620, is a glucokinase activator. Piragliatin greatly enhances glucose-induced pancreatic islet respiration and insulin release. Piragliatin lowers plasma glucose both in the postabsorptiv... |